Levetiracetam — 100 mg/mL, Injection, 25 × 5 mL vial, single-dose in 1 carton

Levetiracetam — 100 mg/mL, Injection, 25 × 5 mL vial, single-dose in 1 carton

Levetiracetam is a injection for intravenous use. Levetiracetam Injection is indicated for the treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) • Levetiracetam Injection is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in. Supplied as 25 × 5 mL vial, single-dose in 1 carton; NDC 0143-9574-25; manufacturer Hikma Pharmaceuticals USA Inc. Rx only. Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. 2 Storage Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature].

• Active ingredient or product type: LEVETIRACETAM
• Strength/concentration: 100 mg/mL
• Dosage form and route: Injection, Intravenous
• Exact package presentation: 25 × 5 mL vial, single-dose in 1 carton
• NDC/item number: 0143-9574-25
• Manufacturer/labeler: Hikma Pharmaceuticals USA Inc.
• Storage/handling: Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. 2 Storage Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature].
• Status: Rx only

Important safety information: Behavioral abnormalities including psychotic symptoms, suicidal ideation, irritability, and aggressive behavior have been observed; monitor patients for psychiatric signs and symptoms ( 5.1 ) Monitor for somnolence and fatigue; advise patients not to drive or operate machinery until they have.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.